Q3 2025 OptimizeRx Corp Earnings Call Transcript

Nov 6, 2025 / 09:30 PM GMT

Release Date Price: $18.94 (-1.15%)

Transcript 10-Q8-K

Key Points

Positve

OptimizeRx Corp (OPRX) is transitioning towards a predictive revenue model, providing better visibility into future financial performance.
The company has experienced strong RFP (Request for Proposal) activity, indicating robust demand in both the healthcare provider (HCP) and direct-to-consumer (DTC) segments.
There is significant growth in the mid-tier client segment, allowing smaller clients to compete effectively using OptimizeRx Corp (OPRX)'s technology.
The company has successfully smoothed its revenue model, reducing periodic revenue drops and enhancing predictability.
OptimizeRx Corp (OPRX) has seen gross margin expansion driven by favorable product and channel partner mix, as well as growth in its data-driven platforms.

Negative

Fourth-quarter revenue guidance suggests a slight year-over-year decline at the top end, raising concerns about growth sustainability.
The adjusted EBITDA guidance indicates potential challenges in achieving significant profitability improvements.
The company is taking a conservative approach to guidance, not factoring in potential 'bluebird' opportunities or pipeline prospects.
Managed services revenue, which is lower margin, has normalized, potentially impacting overall margin expansion.
The partnership with Lamar Advertising is still in its early stages, with no contributions factored into the 2026 guidance, indicating uncertainty in new revenue streams.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OPRX.OQ - OPTIMIZERx Corp
Q3 2025 OptimizeRx Corp Earnings Call
Nov 06, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We've been really articulating to the street and also to our clients and investors that we're going to give more visibility on our visibility into the future as we've been migrating more toward a predictive model we've quoted in the past subscriptive momentum and so we're we're going to continue to push that throughout the remainder of the year. And as a result of that we're now getting more visibility into the out years including, 2026 in terms of the RFP situation, Ryan, RFP season's been very strong for the business. We do see more people coming into the digital space and making investments on the client side. And and and we're seeing, equal parts HCP and DTC at this point, interest in the RFP cycle. I would say the parts of DTC that we cover

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.